News

It's no secret that pharmaceutical companies have been criticised for their unequal access to COVID-19 vaccines. Oxfam has won several battles to obtain pricing and intellectual property information from Johnson & Johnson, Pfizer, and Moderna. Shareholders of J&J will have an...

Singapore is the first country in WHO's categorization of regulatory authority for medical goods to obtain the highest maturity level (ML 4) out of 28 nations formally examined. With ML 4, Singapore is one step closer to being a...

In the fight against COVID-19, the world may soon have another vaccine choice. A positive result from late-stage clinical testing of a novel vaccine that will be called Vidprevtyn has been announced by Sanofi and GSK by the formers...

On the opening day of the 19th edition of BioAsia, a special fireside chat between Dr. Sangita Reddy, MD, of Apollo Hospitals and Dr. Drew Weissman, the pioneer who has brought mRNA tech to vaccines, spotlighted a revolutionary revelation...

25th February 2022 - Trust isn’t just assumed in the life sciences; it’s built, tested, and validated. That professional approach has shaped Dr. Pranesh Sujaymeendra Davangere Srinivas’s journey from raising fruit flies in a makeshift lab to leading global...

WHO along with its academy and the Republic of Korea, have announced the inception of a global bio manufacturing training hub that will be of assistance to low and mid-income countries who are inclined to develop biologicals ranging from...

Earlier in February this year, Novartis, which happens to be a Swiss drug major, sold its three rooted brands to Dr Reddy’s Laboratories in India. If this wasn’t enough, they also went on to terminate 400 employees from positions,...